Armata Pharmaceuticals, Inc. (ARMP)

$4.07

+0.01 (+0.25%)
Rating:
Recommendation:
-
Symbol ARMP
Price $4.07
Beta 0.184
Volume Avg. 0.00M
Market Cap 147.071M
Shares () -
52 Week Range 2.82-6.49
1y Target Est -
DCF Unlevered ARMP DCF ->
DCF Levered ARMP LDCF ->
ROE -71.85% Strong Sell
ROA -29.17% Sell
Operating Margin -
Debt / Equity 89.50% Buy
P/E -
P/B 2.75 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ARMP news


Mr. Todd Patrick
Healthcare
Biotechnology
American Stock Exchange

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.